Advertisement

Topics

Cyberkinetics Neurotechnology Company Profile

09:51 EDT 25th June 2018 | BioPortfolio

Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time neural signal decoding technology, and neural stimulation. The Company's mission is to commercialize products based upon these powerful platform technologies that restore function, including limb movement, sensation and communication, for those with a wide range of central nervous system conditions, diseases and injuries, such as spinal cord injury, ALS and other motor neuron diseases. Cyberkinetics' proprietary neural stimulation technology platform is being developed to regenerate neural fibers that form functional connections, restoring tactile sensation and movement for those with spinal cord injuries and, ultimately, a wide range of central nervous system injuries, diseases and conditions. Cyberkinetics' proprietary neural sensing technology platform provides the ability to sense, transmit, analyze and apply the language of neurons in both short- and long-term settings. Our award-winning technology was originally developed and sold as research products to neuroscientist around the world. Today, we are broadening the application of our technology to develop clinical products. We pride ourselves on a Management Team and Board of Directors with proven track records at leading medical device and biotechnology companies. Cyberkinetics is publicly traded on the Over the Counter Bulletin Board under the ticker symbol, CYKN. The Company is headquartered in Foxborough, Massachusetts, and conducts engineering, research and manufacturing operations in Salt Lake City, Utah.

Location

100 Foxborough Boulevard, Suite 240
Foxborough
MA
02035
United States of America

Contact

Phone: 508-549-9981
Fax: 508-549-9985
Email: info@cyberkineticsinc.com


News Articles [10 Associated News Articles listed on BioPortfolio]

Neurotechnology, Elon Musk and the Goal of Human Enhancement

(The Guardian) – Musk is not alone in believing that “neurotechnology” could be the next big thing. Silicon Valley is abuzz with similar projects. Bryan Johnson, for example, has also been t...

Pour le communiqué de presse du 24 avril 2018 à 3 h HAE Neurotechnology identifie plus de 5 ...

« Dans le processus de nettoyage du registre des électeurs, notre but est de trouver autant de doublons et d'autres cas non conformes que possible, a Read more...

Neurotechnology Identifies More Than 5 Million Duplicates in Massive Voter Deduplication in ...

"In the voter registry cleaning process our goal is to find as many duplicates and other noncompliant cases as possible," said Mr. Corneille Nangaa Yobeluo, Read more...

Ethicists create framework to regulate brain technology

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ba

From healthcare to warfare: How to regulate brain technology

(University of Basel) Ethicists from the University of Basel have outlined a new biosecurity framework specific to neurotechnology. While the researchers declare an outright ban of dual-use technology...

Wyss Center announces collaboration with CorTec

(Wyss Center for Bio and Neuroengineering) The Wyss Center, a non-profit neurotechnology translation organization, has signed a partnership agreement with German medical engineering company, CorTec. T...

Press registration open for Cognitive Neuroscience Society Meeting in Boston, March 24-27, 2018

(Cognitive Neuroscience Society) Join us in Boston to explore the nature of how we think! Press registration is now open for the Cognitive Neuroscience Society annual conference, March 24-27, 2018, in...

CORRECTING and REPLACING Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company Sollis Therapeutics

Pioneering therapy to enter US pivotal trial for treatment of pain from sciatica Please replace the release with the following corrected version due to multiple revisio...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

From Healthcare to Warfare and Reverse: How Should We Regulate Dual-Use Neurotechnology?

Recent advances in military-funded neurotechnology and novel opportunities for misusing neurodevices show that the problem of dual use is inherent to neuroscience. This paper discusses how the neurosc...

Neural data science: accelerating the experiment-analysis-theory cycle in large-scale neuroscience.

Modern large-scale multineuronal recording methodologies, including multielectrode arrays, calcium imaging, and optogenetic techniques, produce single-neuron resolution data of a magnitude and precisi...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

HIRREM for Pre-Hypertension

This randomized, controlled clinical pilot trial will evaluate the effects associated with in-office use of closed-loop, acoustic stimulation neurotechnology (High-resolution, relational, ...

Cognitive Training Delivered Remotely to Individuals With Schizophrenia

The purpose of this study is to use remote methods and scalable interactive neurotechnology to generate important data on the potential for remote targeted cognitive treatment in people wi...

Companies [16 Associated Companies listed on BioPortfolio]

Cambridge Neurotechnology Ltd.

Welcome to the Cambridge Neurotechnology web site. Cambridge Neurotechnology was founded in 1995 and in 1996 introduced the Actiwatch activity monitoring system. As the first truly light-weight system...

Neurotechnology Industry Organization

The Neurotechnology Industry Organization is the trade association that represents companies involved in neuroscience including software, drugs, devices, and diagnostics, brain re...

Neurotechnology Innovations Translator

Columbus, OH based Neurotechnology Innovations Translator (NIT) has a mission to collaborate with scientists and entrepreneurs working to translate innovative science into commerc...

Neurotechnology

SAM TECHNOLOGY, Inc

SAM TECHNOLOGY, Inc. (SAM) is a privately held neurotechnology R&D lab located in downtown San Francisco. Founded in 1986 by Alan Gevins, an MIT engineer and internationally known neuroscientist, SAM ...

More Information about "Cyberkinetics Neurotechnology" on BioPortfolio

We have published hundreds of Cyberkinetics Neurotechnology news stories on BioPortfolio along with dozens of Cyberkinetics Neurotechnology Clinical Trials and PubMed Articles about Cyberkinetics Neurotechnology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyberkinetics Neurotechnology Companies in our database. You can also find out about relevant Cyberkinetics Neurotechnology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record